Boston, MA, United States of America

Alexis Borisy

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 5.8

ph-index = 7

Forward Citations = 357(Granted Patents)


Location History:

  • Arlington, MA (US) (2011 - 2019)
  • Boston, MA (US) (2003 - 2022)

Company Filing History:


Years Active: 2003-2022

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Journey of Alexis Borisy: A Pioneer in CRISPR Technology

Introduction: Alexis Borisy, a prominent inventor based in Boston, MA, has made significant strides in the field of biotechnology with a focus on CRISPR-related methods. With 14 patents to her name, her work has contributed to groundbreaking advancements in genetic editing and molecular biology.

Latest Patents: Among her latest innovations, Borisy has developed methods and compositions related to CRISPR technology that utilize governing gRNA molecules. These patents describe processes for targeting a payload to, or editing a target nucleic acid, where a governing gRNA molecule plays a crucial role in directing, and potentially inactivating, a Cas9 molecule or a Cas9 molecule/gRNA complex.

Career Highlights: Throughout her career, Borisy has worked at notable organizations, including CombinatoRx, Incorporated and Editas Medicine, Inc. These positions have allowed her to leverage her expertise in genetic editing technologies and contribute to significant research projects.

Collaborations: In her quest for innovation, Borisy has collaborated with several esteemed individuals in the field, including her coworkers Curtis Keith and Michael Andrew Foley. Their combined efforts emphasize a commitment to advancing the capabilities of genetic engineering.

Conclusion: Alexis Borisy stands out as a key figure in the world of biotechnological innovations. Her contributions, particularly in the realm of CRISPR, showcase the transformative potential of her inventions and highlight her role as a leader in shaping the future of genetics. With her ongoing work, the impact of her patents is likely to resonate for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…